Medical Device Opportunities in India’s TB Fight
Written by Susi, Arushi Sharma
India's fight against tuberculosis (TB) has opened up significant opportunities in the realm of medical devices. With a high TB burden, the country is actively seeking innovative solutions to bolster its TB control efforts.
According to GlobalData, the Indian market for mycobacterium tuberculosis tests is expected to grow at a 4% annual rate between 2023 and 2033. In 2023, India will have the highest incidence of mycobacterium tuberculosis in the Asia-Pacific (APAC) region.
The "India Fights TB" initiative, led by HEAL Foundation and Mylan Pharmaceuticals Private Limited, takes a comprehensive approach, addressing medical advancements, social stigma, and treatment adherence to empower patients to complete their treatment.
Rachna Tripathi, Medical Devices Analyst, GlobalData, comments, “The launch of the ‘India Fights TB’ initiative is commendable in the ongoing battle against tuberculosis in India. With a staggering 2.64 million reported cases in 2022, tuberculosis remains a formidable public health challenge. Initiatives like this one are not just important but also reflect the collective commitment to spreading awareness, reducing the stigma surrounding the disease, and ensuring that individuals receive timely diagnosis and treatment.”
India's TB strategy prioritizes patient care, leading to the development of user-friendly medical devices for diagnosis, monitoring, and treatment adherence. As TB management expands to community settings, mobile devices like the "TB-Mukt Express" are increasingly sought.
Medical device companies can now develop solutions for community health settings, enhancing early detection and intervention by healthcare workers and bolstering the fight against tuberculosis.
Tripathi concludes, “Amid the sustained efforts to tackle tuberculosis, initiatives like ‘India Fights TB’ shine brightly as beacons of hope toward a healthier and TB-free India. Through proactive efforts in raising awareness, improving diagnosis, and ensuring treatment adherence, India has the potential to take substantial steps in conquering the formidable challenges posed by this health crisis. As India leads the charge against TB, the medical device sector stands poised for innovation, growth, and meaningful contributions to global health.”